EpimAb Biotherapeutics to Present a Late-Breaking Abstract of First-in-Human Data of EMB-06 at 2023 SITC Annual Meeting
SHANGHAI--(BUSINESS WIRE)--EpimAb Biotherapeutics, a clinical stage biotechnology company specializing in the development of bispecific antibodies,…